Discovery of small molecule antagonists of TRPV1
- 16 July 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (14), 3631-3634
- https://doi.org/10.1016/j.bmcl.2004.05.028
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonistNeuropharmacology, 2003
- Vanilloid and TRP channels: a family of lipid-gated cation channelsNeuropharmacology, 2002
- The diversity in the vanilloid (TRPV) receptor family of ion channelsTrends in Pharmacological Sciences, 2002
- Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgeryBritish Journal of Anaesthesia, 2002
- Characterisation using FLIPR of human vanilloid VR1 receptor pharmacologyEuropean Journal of Pharmacology, 2001
- In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analoguePain, 2000
- The capsaicin receptor: a heat-activated ion channel in the pain pathwayNature, 1997
- Capsazepine block of voltage‐activated calcium channels in adult rat dorsal root ganglion neurones in cultureBritish Journal of Pharmacology, 1997
- Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal gangliaNeuroscience Letters, 1997
- Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicinBritish Journal of Pharmacology, 1992